Xian Wu

Integrated tumor genomic and immune microenvironment analysis identifies predictive biomarkers associated with the efficacy of neoadjuvant therapy for triple‐negative breast cancer

Haitao Luo, Yanhui Zhu, Xiaoan Liu, 2022, Cancer medicine.

MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2

C. Peng, Henan Zhao, S. Cui, 2016, Oncotarget.

MicroRNA‐23a promotes colorectal cancer cell survival by targeting PDK4

Hui Gao, Shao-Hui Tang, Hui Tang, 2018, Experimental cell research.

Expression of miR-136 is associated with the primary cisplatin resistance of human epithelial ovarian cancer.

Henan Zhao, S. Cui, Ji-yong Jiang, 2015, Oncology reports.

MiR-29 a regulated FOXO 3 expression and promoted the cell proliferation of human cervical cancer

Hong Chen, Xiaoliang Zhou, Xian Wu, 2016 .

Tiliroside induces ferroptosis to repress the development of triple-negative breast cancer cells.

L. Ye, Jianfang Zhao, Chuangying Hu, 2023, Tissue & cell.

LHX2 Is a Potential Biomarker and Associated with Immune Infiltration in Breast Cancer

Yanhui Zhu, Xiaoan Liu, Junzhe Yang, 2023, Cancers.

FTO‐mediated epigenetic upregulation of LINC01559 confers cell resistance to docetaxel in breast carcinoma by suppressing miR‐1343‐3p

Ling Chen, Kunlin Wu, Ling-jun Kong, 2023, The Kaohsiung journal of medical sciences.